Overview

Update
Total Equity Funding
$161.3M in 8 Rounds from 13 Investors
Most Recent Funding
$34.3M Series F on April 27, 2015
Headquarters:
Malvern, PA
Description:
Neuronetics, a medical device company, develops non-invasive therapies for psychiatric and neurological disorders.
Founders:
,
Categories:
Therapeutics, Medical Device, Biotechnology
Website:
http://www.neuronetics.com
Social:

Company Details

Update

Neuronetics, Inc. is a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. Based in Malvern, PA, they are the leader in the development of TMS Therapy (transcranial magnetic stimulation), a non-invasive form of neuromodulation.

Funding Rounds (8) - $161.3M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2015$34.3M / Series F9
May, 2011$30M / Series E8
Oct, 2009$30M / Series D8
Aug, 2006$35M / Series C6
Nov, 2005$8.5M / Series B5
Mar, 2005$8.5M / Series B5
Aug, 2003undisclosed amount / Seed2
Apr, 2003$15M / Series A4

Current Team (12)

Update

Offices/Locations (1)

Update
  • Office

    31 General Warren Blvd.

    Malvern, PA 19355

    USA

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos